| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2000;69:1388-1392
© 2000 The Society of Thoracic Surgeons
a Departments of Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, Ohio, USA
b Department of Infection Control, Cleveland Clinic Foundation, Cleveland, Ohio, USA
c Department of Cardiothoracic Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Address reprint requests to Dr Gordon, Department of Infectious Diseases, The Cleveland Clinic, 9500 Euclid Ave, Mailstop S32, Cleveland, OH 44195-5066
e-mail: gordons{at}cesmtp.ccf.org
Background. We reviewed all cases of early onset prosthetic valve endocarditis (EO-PVE) occurring less than 12 months after valve operation among 7,043 patients undergoing heart valve replacements or repairs at The Cleveland Clinic between 1992 and 1997.
Methods. Cases were defined by the Duke criteria and identified through prospective surveillance.
Results. Seventy-seven cases of EO-PVE were identified (1 per 100 procedures), and during the study period the incidence of EO-PVE decreased from 1.5% (1992 to 1994) to 0.7% (1995 to 1997) (p < 0.01). The incidence of EO-PVE for rings (0.2%; 4 of 1,992) was significantly lower than for mechanical (1.6%; 28 of 1,731) and bioprosthetic valves (1.1%; 41 of 3,320) (p < 0.001). The incidence of EO-PVE was also significantly lower for mitral valve versus aortic valve surgeries (0.6% versus 1.4%, p < 0.001). The most common pathogens causing EO-PVE were coagulase-negative staphylococci (52%), fungi (13%), Staphylococcus aureus (10%), and enterococci (8%). Patients undergoing combined surgical and medical treatment of EO-PVE had a significantly higher 30-day, 2-year, and 3-year survival than medically treated patients, although patients judged to be too ill to survive surgery accounted for two-thirds of the patients treated medically.
Conclusions. There is a 1% incidence rate of EO-PVE among patients undergoing valve operations at our institution, usually caused by coagulase-negative staphylococci, and combined surgical and medical treatment is associated with improved survival compared with medical treatment alone.
This article has been cited by other articles:
|
|
 |
|
  F. Thuny, P. E. Fournier, J. P. Casalta, F. Gouriet, H. Lepidi, A. Riberi, F. Collart, G. Habib, and D. Raoult Investigation of blood culture-negative early prosthetic valve endocarditis reveals high prevalence of fungi Heart, May 1, 2010; 96(10): 743 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Prendergast and P. Tornos Surgery for Infective Endocarditis: Who and When? Circulation, March 9, 2010; 121(9): 1141 - 1152. [Full Text] [PDF]
|
|
|
|
 |
|
 Endorsed by the European Society of Clinical Micro, Authors/Task Force Members, G. Habib, B. Hoen, P. Tornos, F. Thuny, B. Prendergast, I. Vilacosta, P. Moreillon, M. de Jesus Antunes, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC) Eur. Heart J., October 1, 2009; 30(19): 2369 - 2413. [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. David Surgical Treatment of Aortic Valve Endocarditis Card. Surg. Adult, January 1, 2008; 3(2008): 949 - 956. [Full Text]
|
|
|
|
|
|
S. C. Stamou, G. Petterson, and A. M. Gillinov Surgical Treatment of Mitral Valve Endocarditis Card. Surg. Adult, January 1, 2008; 3(2008): 1069 - 1078. [Full Text]
|
|
|
|
 |
|
 T. Shibata, Y. Sasaki, H. Hirai, T. Fukui, M. Hosono, and S. Suehiro Early surgery for hospital-acquired and community-acquired active infective endocarditis Interact CardioVasc Thorac Surg, June 1, 2007; 6(3): 354 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lopez, A. Revilla, I. Vilacosta, E. Villacorta, C. Gonzalez-Juanatey, I. Gomez, M. J. Rollan, and J. A. San Roman Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis Eur. Heart J., March 2, 2007; 28(6): 760 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schmidtke, G. Dahmen, and H.-H. Sievers Subcoronary Ross Procedure in Patients With Active Endocarditis Ann. Thorac. Surg., January 1, 2007; 83(1): 36 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Habib, C Tribouilloy, F Thuny, R Giorgi, A Brahim, M Amazouz, J-P Remadi, G Nadji, J-P Casalta, F Coviaux, et al. Prosthetic valve endocarditis: who needs surgery? A multicentre study of 104 cases Heart, July 1, 2005; 91(7): 954 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Delahaye, M Celard, O Roth, and G de Gevigney Indications and optimal timing for surgery in infective endocarditis Heart, June 1, 2004; 90(6): 618 - 620. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lee and M. R. Moon Homograft valve repair for recurrent prosthetic valve endocarditis J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 725 - 727. [Full Text] [PDF]
|
|
|
|
|
|
F. J. Schoen and R. F. Padera Jr. Cardiac Surgical Pathology Card. Surg. Adult, January 1, 2003; 2(2003): 119 - 185. [Full Text]
|
|
|
|
|
|
T. E. David Surgical Treatment of Aortic Valve Endocarditis Card. Surg. Adult, January 1, 2003; 2(2003): 857 - 866. [Full Text]
|
|
|
|
 |
|
 I. A. Khan and N. J. Mehta Stenotrophomonas maltophilia Endocarditis: A Systematic Review Angiology, January 1, 2002; 53(1): 49 - 55. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Hamanaka, N. Mitsui, and S. Hirai Repeat Tricuspid and Mitral Valve Replacement for Enterococcal Endocarditis Asian Cardiovasc Thorac Ann, December 1, 2001; 9(4): 318 - 319. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
